The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Reversing resistance to PD-1 blockade by combination of talimogene laherparepvec (T-VEC) with pembrolizumab (pembro) in advanced melanoma patients following progression on a prior PD-1 inhibitor: SWOG S1607 (NCT#02965716).
 
Siwen Hu-Lieskovan
Consulting or Advisory Role - Amgen; Genmab; Merck
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Nektar (Inst); Neon Therapeutics (Inst); Pfizer (Inst); Plexxikon (Inst); Vaccinex (Inst)
 
James Moon
No Relationships to Disclose
 
Danae Campos
Employment - QTC Management- A Leidos Company
Travel, Accommodations, Expenses - QTC Management- A Leidos Company
 
Kenneth F. Grossmann
Consulting or Advisory Role - Bristol-Myers Squibb (I); Castle Biosciences; Roche/Genentech
 
Jeffrey Alan Sosman
Honoraria - Amgen; Array BioPharma; Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Merck
 
Christopher W. Ryan
Consulting or Advisory Role - Eisai; Exelixis; Genentech/Roche; Novartis; Pfizer
Research Funding - Argos Therapeutics (Inst); Bristol-Myers Squibb (Inst); CytRx Corporation (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline/Novartis (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MabVax (Inst); Merck (Inst); Morphotek (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst)
 
Michael Wu
No Relationships to Disclose
 
Antoni Ribas
Stock and Other Ownership Interests - Advaxis; Arcus Biosciences; Compugen; CytomX Therapeutics; Five Prime Therapeutics; FLX Bio; PACT Pharma; Tango Therapeutics
Consulting or Advisory Role - Amgen; Genentech/Roche; Merck; Novartis